SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1.71 Cr | ₹1.35 Cr | ₹2.46 Cr | ₹3.58 Cr | ₹4.50 Cr |
What is the latest Total Non-Current Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1.71 Cr |
| Mar2024 | ₹1.35 Cr |
| Mar2023 | ₹2.46 Cr |
| Mar2022 | ₹3.58 Cr |
| Mar2021 | ₹4.50 Cr |
How is Total Non-Current Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.71 Cr | 27.12 | |
| Mar2024 | ₹1.35 Cr | -45.33 | |
| Mar2023 | ₹2.46 Cr | -31.13 | |
| Mar2022 | ₹3.58 Cr | -20.61 | |
| Mar2021 | ₹4.50 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹4,457.8 Cr | 25.8% | 24.7% | 48.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | 25.8% |
24.7% |
48.1% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses